Effects of Olopatadine Hydrochloride, a Histamine H1 Receptor Antagonist, on Histamine-Induced Skin Responses
Effects of olopatadine hydrochloride, a histamine H1 receptor antagonist, on histamine-induced skin responses were evaluated in 10 healthy subjects in comparison with placebo, fexofenadine hydrochloride, and bepotastine besilate. Olopatadine significantly suppressed histamine-induced wheal, flare, a...
Saved in:
Published in | Dermatology Research and Practice Vol. 2010; no. 2010; pp. 1 - 4 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cairo, Egypt
Hindawi Puplishing Corporation
01.01.2010
Hindawi Publishing Corporation Wiley John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1687-6105 1687-6113 1687-6113 |
DOI | 10.1155/2010/638051 |
Cover
Summary: | Effects of olopatadine hydrochloride, a histamine H1 receptor antagonist, on histamine-induced skin responses were evaluated in 10 healthy subjects in comparison with placebo, fexofenadine hydrochloride, and bepotastine besilate. Olopatadine significantly suppressed histamine-induced wheal, flare, and itch, starting 30 minutes after oral administration. Olopatadine was more effective than fexofenadine and bepotastine. None of the drugs studied impaired performance of word processing tasks. These results suggest that olopatadine can suppress skin symptoms caused by histamine soon after administration. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 Academic Editor: Thilo Gambichler |
ISSN: | 1687-6105 1687-6113 1687-6113 |
DOI: | 10.1155/2010/638051 |